Skip to main content

Table 2 Baseline characteristics associated with deficient blood 25-hydroxyvitamin D (< 30 ng/mL versus ≥ 30 ng/mL) by univariable logistic regression

From: Abnormal blood 25-hydroxyvitamin D in critically ill patients: prevalence, predictors, and its association with in-hospital mortality

 

No. patients

No. patients with 25(OH)D  < 30 ng/mL

Odds ratio

95% CI

P value

Age (years)

1091

790

0.97

0.96–0.98

 < 0.001

Sex

 Male

553

424

1 (Reference)

  

 Female

538

366

0.65

0.50–0.85

0.002

Marital status

 Single

383

298

1 (Reference)

  

 Married

420

301

0.72

0.52–0.99

0.046

 Divorced

87

62

0.71

0.42–1.19

0.195

 Widowed

113

65

0.39

0.25–0.60

 < 0.001

 Unknown

88

64

0.76

0.45–1.29

0.309

Ethnicity

 White

671

466

1 (Reference)

  

 Black/African American

157

127

1.86

1.21–2.86

0.005

 Hispanic/Latino

44

36

1.98

0.90–4.33

0.088

 Asian

39

33

2.42

1.00–5.86

0.050

 Other/unknown

180

128

1.08

0.75–1.55

0.666

Type of intensive care unit

 Medical Intensive Care Unit

379

280

1 (Reference)

  

 Medical/Surgical Intensive Care Unit

241

175

0.94

0.65–1.35

0.728

 Cardiac Vascular Intensive Care Unit

55

34

0.57

0.32–1.03

0.064

 Surgical Intensive Care Unit

181

139

1.17

0.77–1.77

0.457

 Trauma Surgical Intensive Care Unit

102

75

0.98

0.60–1.61

0.943

 Coronary Care Unit

89

58

0.66

0.40–1.08

0.100

 Neuro Surgical Intensive Care Unit

25

16

0.63

0.27–1.47

0.283

 Neuro Intermediate

13

11

1.94

0.42–8.93

0.392

 Neuro Stepdown

5

2

0.24

0.04–1.43

0.116

 Post-anesthesia Care Unit

1

0

Glasgow Coma Scale

1091

790

1.00

0.96–1.04

0.921

SOFA

1091

790

1.02

0.99–1.05

0.248

SAPS II

1091

790

1.00

0.99–1.00

0.342

Charlson Comorbidity Index

1091

790

0.96

0.92–1.00

0.078

Comorbidities$

 Myocardial infarction

158

103

0.67

0.47–0.96

0.029

 Congestive heart failure

354

245

0.79

0.60–1.05

0.101

 Peripheral vascular disease

106

79

1.13

0.71–1.78

0.608

 Chronic pulmonary disease

269

189

0.87

0.64–1.18

0.364

 Mild liver disease

296

236

1.71

1.24–2.36

0.001

 Severe liver disease

217

172

1.58

1.11–2.27

0.012

 Renal disease

378

263

0.81

0.61–1.06

0.128

 Dialysis

164

131

1.61

1.07–2.43

0.021

 Diabetes without complications

264

199

1.22

0.89–1.68

0.216

 Diabetes with complications

178

137

1.33

0.91–1.94

0.138

 Cerebrovascular disease

119

81

0.79

0.52–1.19

0.262

 Dementia

47

28

0.55

0.30–0.99

0.047

 Paraplegia

43

29

0.78

0.41–1.50

0.458

 Rheumatic disease

49

29

0.54

0.30–0.96

0.037

 Malignant tumor

183

138

1.20

0.83–1.74

0.320

 Acquired immunodeficiency syndrome

14

10

0.95

0.30–3.06

0.934

  1. CI confidence interval, SOFA Sequential Organ Failure Assessment, SAPS II, Simplified Acute Physiology Score II
  2. $Versus patients without the commodities